UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in IBRX — ImmunityBio, Inc.
CIK 861177
NEW YORK, NY
Position in IBRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,657,279
+$571,666 QoQ
Shares Held
531,957
-0.1% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 403 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. IBRX ranks #65 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in IBRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,657,279 | 531,957 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $4,085,613 | 532,675 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $913,125 | 461,176 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,040,162 | 422,831 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,063,951 | 781,800 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,301,343 | 432,341 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $670,035 | 261,734 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,746,660 | 1,544,802 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,971,864 | 1,577,827 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $982,331 | 182,930 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $918,306 | 182,930 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $309,149 | 182,930 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $508,543 | 182,930 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $332,930 | 182,930 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $746,292 | 147,198 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $672,711 | 135,355 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $573,015 | 154,037 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $565,827 | 100,861 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $613,232 | 100,861 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $420,172 | 43,139 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $370,165 | 25,922 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $515,158 | 21,700 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 NK | — | 12,200 | Shares | Sole | 2021-03-01 | |
| No filing history on record for this holder in this stock. | ||||||